MUMPS VIRUS - ANVISA Registration 10338930140
Access comprehensive regulatory information for MUMPS VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930140 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VIRCELL S.L., DIASORIN ITALIA S.P.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10338930140
25351416014201413
93741726000166
Company Information
Dates and Status
Dec 08, 2014
VIGENTE
09/18/2025 19:00:01
MEASLES
Sarampo IgG
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930143
Dec 15, 2014
MEASLES
Sarampo IgG
Not specified
10338930143
Dec 15, 2014
IMMUNOGLOBULIN G
MAGLUMI IgG (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102511861
Oct 02, 2017
IMMUNOGLOBULIN M
IGM2, TINA-QUANT IGM GEN.2
ROCHE DIAGNOSTICS GMBH
10287410573
Oct 23, 2006
IMMUNOGLOBULIN G
IMUNOGLOBULINA G IgG
BIOSYSTEMS S/A
10300390193
Dec 17, 2018
VÍRUS DA CAXUMBA
MUMPS VIRCLIA® IgM
VIRCELL S.L.
10259610256
Apr 28, 2025
VÍRUS DA CAXUMBA
MUMPS VIRCLIA IgG
VIRCELL S.L.
10259610255
Apr 07, 2025
VÍRUS DA CAXUMBA
MUMPS ELISA IgG/IgM
VIRCELL S.L.
10259610252
Jul 22, 2024
VÍRUS DA CAXUMBA
MUMPS VIRCLIA® IgM MONOTEST
VIRCELL S.L.
81816720049
Aug 21, 2023
VÍRUS DA CAXUMBA
MUMPS VIRCLIA® IgG MONOTEST
VIRCELL S.L.
81816720051
Aug 21, 2023